WO2002006446A3 - Haplotypes du gene edg6 - Google Patents

Haplotypes du gene edg6 Download PDF

Info

Publication number
WO2002006446A3
WO2002006446A3 PCT/US2001/022523 US0122523W WO0206446A3 WO 2002006446 A3 WO2002006446 A3 WO 2002006446A3 US 0122523 W US0122523 W US 0122523W WO 0206446 A3 WO0206446 A3 WO 0206446A3
Authority
WO
WIPO (PCT)
Prior art keywords
edg6
gene
haplotypes
disclosed
haplotyping
Prior art date
Application number
PCT/US2001/022523
Other languages
English (en)
Other versions
WO2002006446A2 (fr
Inventor
Stefanie E Kliem
Beena Koshy
Original Assignee
Genaissance Pharmaceuticals
Stefanie E Kliem
Beena Koshy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Stefanie E Kliem, Beena Koshy filed Critical Genaissance Pharmaceuticals
Priority to AU2001273541A priority Critical patent/AU2001273541A1/en
Publication of WO2002006446A2 publication Critical patent/WO2002006446A2/fr
Publication of WO2002006446A3 publication Critical patent/WO2002006446A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Cette invention se rapporte à de nouveaux variants génétiques du gène de récepteur 6 couplé à la protéine G à différenciation endothéliale (EDG6). Divers génotypes, haplotypes et paires d'haplotypes qui existent dans la population générale des Etats-Unis sont divulgués pour le gène EDG6. Des compositions et des procédés permettant de déterminer l'haplotype et/ou le génotype du gène EDG6 chez un individu sont également divulgués. Des polynucléotides définis par les haplotypes ainsi divulgués sont également décrits.
PCT/US2001/022523 2000-07-17 2001-07-17 Haplotypes du gene edg6 WO2002006446A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001273541A AU2001273541A1 (en) 2000-07-17 2001-07-17 Haplotypes of the edg6 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21872700P 2000-07-17 2000-07-17
US60/218,727 2000-07-17

Publications (2)

Publication Number Publication Date
WO2002006446A2 WO2002006446A2 (fr) 2002-01-24
WO2002006446A3 true WO2002006446A3 (fr) 2002-06-06

Family

ID=22816262

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/022523 WO2002006446A2 (fr) 2000-07-17 2001-07-17 Haplotypes du gene edg6

Country Status (2)

Country Link
AU (1) AU2001273541A1 (fr)
WO (1) WO2002006446A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6812335B1 (en) 1999-03-23 2004-11-02 The Regents Of The University Of California Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same
BRPI0908831A2 (pt) * 2008-02-14 2015-08-04 Pioneer Hi Bred Int Métodos para identificar o evento e6611.32.1.38 em amostra biológica, para detectar a presença do evento e6611.32.1.38 ou a progênie deste em uma amostra biológica, para detectar a presença de dna correspondente ao evento e6611.32.1.38 em uma amostra, para selecionar sementes com a presença do evento e6611.32.1.38, molécula de dna isolada, sequência de nucleotídeos de primer de dna, par de sequências de dna isoladas, planta, célula, tecido, semente transgênicos ou partes destes contendo dna.
US8791100B2 (en) 2010-02-02 2014-07-29 Novartis Ag Aryl benzylamine compounds

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] NATIONAL LIBRARY OF MEDICINE, NIH (BETHESDA, MD, USA); 29 January 2001 (2001-01-29), XP002907156, accession no. NCBI Database accession no. (NT011258) *
DATABASE SNP [online] NATIONAL LIBRARY OF MEDICINE, NIH (BETHESDA, MD, USA); 17 April 2001 (2001-04-17), XP002907057, retrieved from GI:13632726 accession no. NCBI Database accession no. (NT011258) *
GRALER ET AL.: "EDG6, a novel G-protein coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue", GENOMICS, vol. 53, 1998, pages 164 - 169, XP002137156 *

Also Published As

Publication number Publication date
AU2001273541A1 (en) 2002-01-30
WO2002006446A2 (fr) 2002-01-24

Similar Documents

Publication Publication Date Title
WO2001090122A3 (fr) Haplotypes du gene ctla4
WO2002006446A3 (fr) Haplotypes du gene edg6
WO2002006294A3 (fr) Haplotypes du gene mmp13
WO2002026764A3 (fr) Haplotypes du gene ccr6
WO2002008425A3 (fr) Haplotypes du gene adrb3
WO2001087904A3 (fr) Haplotypes du gene gpr4
WO2002020556A3 (fr) Haplotypes du gene gpr68
WO2002044200A3 (fr) Haplotypes du gene edg1
WO2002012342A3 (fr) Haplotypes du gene edg4
WO2002050098A3 (fr) Haplotypes du gene du recepteur de la prolactine (prlr)
WO2001090128A3 (fr) Haplotypes du gene gpr3
WO2002038587A3 (fr) Haplotypes du gene grm8
WO2002032928A3 (fr) Haplotypes du gene hrh1
WO2002016399A3 (fr) Haplotypes du gene tacr1
WO2001096350A3 (fr) Haplotypes du gene grm3
WO2002032924A3 (fr) Haplotypes du gene chrm5
WO2002040502A3 (fr) Haplotypes du gene de la lipase hormono-sensible
WO2001090127A3 (fr) Haplotypes du gene de hoxd3
WO2001090124A3 (fr) Haplotypes du gene gpr31
WO2001090118A3 (fr) Haplotypes du gene edn2
WO2002016398A3 (fr) Haplotypes du gene bmpr2
WO2002030949A3 (fr) Haplotypes du gene ltb4r
WO2002026766A3 (fr) Haplotypes du gene sstr4
WO2001087908A3 (fr) Haplotypes du gene ccr3
WO2002012562A3 (fr) Haplotypes du gene pla2g1b

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP